Monkeys Cloned by Dolly-the-Sheep Technology

The approach, which has never before been successfully attempted in primates, could lead to improved animal models for human biology and disease.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Hua Hua, one of two monkeys cloned by somatic cell nuclear transferQIANG SUN & MU-MING POO, CHINESE ACADEMY OF SCIENCESResearchers in China have created the first viable primate clones made using somatic cell nuclear transfer (SCNT), according to a study published yesterday (January 24) in Cell. Two newborn macaques, named Zhong Zhong and Hua Hua, were produced at the Chinese Academy of Sciences’ Institute of Neuroscience (ION) in Shanghai using the same technology made famous by Dolly the Sheep, and could represent a novel model system for scientists studying human biology and disease.

“This paper really marks the beginning of a new era for biomedical research,” Xiong Zhi-Qi, a researcher studying brain disease at the ION but who was not involved in the work, tells Nature.

These monkeys are not the first primates to be cloned. A rhesus macaque named Tetra was produced in the late 1990s by embryo splitting, the division of an early-stage embryo into two or four separate cells to make clones. Zhong Zhong and Hua Hua, by contrast, were each made by replacing an egg cell nucleus with DNA from a differentiated body cell. The technique—which has previously been employed to clone sheep, cattle, cats, mice, and dogs—can create more clones than embryo splitting and allows researchers greater control over the edits they make ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform